38 results on '"Reddy, U M"'
Search Results
2. Unravelling caesarean delivery as a risk factor for antepartum stillbirth
- Author
-
Reddy, U M
- Published
- 2015
- Full Text
- View/download PDF
3. The association of beta-2 adrenoceptor genotype with short-cervix mediated preterm birth: a case–control study
- Author
-
Miller, R, Smiley, R, Thom, E A, Grobman, W A, Iams, J D, Mercer, B M, Saade, G, Tita, A T, Reddy, U M, Rouse, D J, Sorokin, Y, Blackwell, S C, Esplin, M S, Tolosa, J E, and Caritis, S N
- Published
- 2015
- Full Text
- View/download PDF
4. Supplement to: Karyotype versus microarray testing for genetic abnormalities after stillbirth.
- Author
-
Reddy, U M, Page, G P, and Saade, G R
- Published
- 2012
5. § Using a simplified Bishop score to predict vaginal delivery
- Author
-
Laughon, S K, Zhang, J, Troendle, J, Sun, L, and Reddy, U M
- Published
- 2011
6. Recurrence risk of stillbirth in the second pregnancy
- Author
-
Herring, A H and Reddy, U M
- Published
- 2010
- Full Text
- View/download PDF
7. POPULATION MODIFIED DEFINITION OF THE VBAC RATE IS NECESSARY.
- Author
-
Reddy, U M, DiVito, M M, Armstrong, J, Phillips, L M, and Wapner, R J
- Published
- 2000
8. Predicting Vaginal Delivery in Nulliparous Women Undergoing Induction of Labor at Term
- Author
-
Reddy, U. M., primary, Huang, C. C., primary, Auguste, T. C., primary, Bauer, D., primary, Overcash, R. T., primary, and Kawakita, T., additional
- Published
- 2017
- Full Text
- View/download PDF
9. Setting research priorities to improve global newborn health and prevent stillbirths by 2025
- Author
-
Yoshida, S., Martines, J., Lawn, J. E., Wall, S., Souza, J. P., Rudan, I., Cousens, S., Aaby, P., Adam, I., Adhikari, R. K., Ambalavanan, N., Arifeen, S. E. I., Aryal, D. R., Asiruddin, S. K., Baqui, A., Barros, A. J. D., Benn, C. S., Bhandari, V., Bhatnagar, S., Bhattacharya, S., Bhutta, Z. A., Black, R. E., Blencowe, H., Bose, C., Brown, J., Bührer, C., Carlo, W., Cecatti, J. G., Cheung, P., Clark, R., Colbourn, T., Conde-Agudelo, A., Corbett, E., Czeizel, A. E., Abhik Das, Day, L. T., Deal, C., Deorari, A., Dilmen, U., English, M., Engmann, C., Esamai, F., Fall, C., Ferriero, D. M., Gisore, P., Hazir, T., Higgins, R. D., Homer, C. S. E., Hoque, D. E., Irgens, L., Islam, M. T., Graft-Johnson, J., Joshua, M. A., Keenan, W., Khatoon, S., Kieler, H., Kramer, M. S., Lackritz, E. M., Lavender, T., Lawintono, L., Luhanga, R., Marsh, D., Mcmillan, D., Mcnamara, P. J., Mol, B. J., Molyneux, E., Mukasa, G. K., Mutabazi, M., Nacul, L. C., Nakakeeto, M., Narayanan, I., Olusanya, B., Osrin, D., Paul, V., Poets, C., Reddy, U. M., Santosham, M., Sayed, R., Schlabritz-Loutsevitch, N. E., Singhal, N., Smith, M. A., Smith, P. G., Soofi, S., Spong, C. Y., Sultana, S., Tshefu, A., Bel, F., Gray, L. V., Waiswa, P., Wang, W., Williams, S. L. A., Wright, L., Zaidi, A., Zhang, Y., Zhong, N., Zuniga, I., Bahl, R., and APH - Amsterdam Public Health
- Subjects
priorities ,newborn ,Research ,lcsh:Public aspects of medicine ,lcsh:R ,Research Theme: Global Health Research Priorities ,lcsh:Medicine ,health ,lcsh:RA1-1270 ,improve - Abstract
Background In 2013, an estimated 2.8 million newborns died and 2.7 million were stillborn. A much greater number suffer from long term impairment associated with preterm birth, intrauterine growth restriction, congenital anomalies, and perinatal or infectious causes. With the approaching deadline for the achievement of the Millennium Development Goals (MDGs) in 2015, there was a need to set the new research priorities on newborns and stillbirth with a focus not only on survival but also on health, growth and development. We therefore carried out a systematic exercise to set newborn health research priorities for 2013–2025. Methods We used adapted Child Health and Nutrition Research Initiative (CHNRI) methods for this prioritization exercise. We identified and approached the 200 most productive researchers and 400 program experts, and 132 of them submitted research questions online. These were collated into a set of 205 research questions, sent for scoring to the 600 identified experts, and were assessed and scored by 91 experts. Results Nine out of top ten identified priorities were in the domain of research on improving delivery of known interventions, with simplified neonatal resuscitation program and clinical algorithms and improved skills of community health workers leading the list. The top 10 priorities in the domain of development were led by ideas on improved Kangaroo Mother Care at community level, how to improve the accuracy of diagnosis by community health workers, and perinatal audits. The 10 leading priorities for discovery research focused on stable surfactant with novel modes of administration for preterm babies, ability to diagnose fetal distress and novel tocolytic agents to delay or stop preterm labour. Conclusion These findings will assist both donors and researchers in supporting and conducting research to close the knowledge gaps for reducing neonatal mortality, morbidity and long term impairment. WHO, SNL and other partners will work to generate interest among key national stakeholders, governments, NGOs, and research institutes in these priorities, while encouraging research funders to support them. We will track research funding, relevant requests for proposals and trial registers to monitor if the priorities identified by this exercise are being addressed.
- Published
- 2016
10. Severe maternal morbidity during delivery hospitalisation in a large international administrative database, 2008-2013: a retrospective cohort.
- Author
-
Lipkind, HS, Zuckerwise, LC, Turner, EB, Collins, JJ, Campbell, KH, Reddy, UM, Illuzi, JL, Merriam, AA, Lipkind, H S, Zuckerwise, L C, Turner, E B, Collins, J J, Campbell, K H, Reddy, U M, Illuzi, J L, and Merriam, A A
- Abstract
Objective: This study utilized the Dr. Foster Global Comparators database to identify pregnancy complications and associated risk factors that led to severe maternal morbidity during delivery hospitalisations in large university hospitals based in the USA, Australia, and England.Design: Retrospective cohort.Setting: Births in the USA, England and Australia from 2008 to 2013.Sample: Data from delivery hospitalisations between 2008 and 2013 were examined using the Dr. Foster Global Comparators database.Methods: We identified delivery hospitalisations with life-threatening diagnoses or use of life-saving procedures, using algorithms for severe maternal morbidity from the Center for Disease Control. Frequency of severe maternal morbidity was calculated for each country.Main Outcome Measures: Multivariable analysis was used to examine the association between morbidity and socio-demographic and clinical characteristics within each country. Chi-square tests assessed differences in covariates between countries.Results: From 2008 to 2013, there were 516 781 deliveries from a total of 18 hospitals: 24.5% from the USA, 57.0% from England and 18.4% from Australia. Overall severe maternal morbidity rate was 8.2 per 1000 deliveries: 15.6 in the USA, 5.0 in England, and 8.2 in Australia. The most common codes identifying severe morbidity included transfusion, disseminated intravascular coagulation, acute renal failure, cardiac events/procedures, ventilation, hysterectomy, and eclampsia. Advanced maternal age, hypertension, diabetes, and substance abuse were associated with severe maternal morbidity in all three countries.Conclusion: Rates of severe maternal morbidity differed by country. Identification of geographical, socio-demographic, and clinical differences can help target modifications of practice and potentially reduce severe maternal morbidity.Tweetable Abstract: Rates of severe maternal morbidity vary, but risk factors associated with adverse outcomes are similar in developed countries. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
11. Cervical funneling or intra-amniotic debris and preterm birth in nulliparous women with midtrimester cervical length less than 30 mm.
- Author
-
Saade, G. R., Thom, E. A., Grobman, W. A., Iams, J. D., Mercer, B. M., Reddy, U. M., Tita, A. T. N., Rouse, D. J., Sorokin, Y., Wapner, R. J., Leveno, K. J., Blackwell, S. C., Esplin, M. S., Tolosa, J. E., Thorp, J. M., Caritis, S. N., Vandorsten, J. P., Moss, J., Salazar, A., and Hankins, G.
- Subjects
PREMATURE labor ,SECOND trimester of pregnancy ,FETAL ultrasonic imaging ,GESTATIONAL age ,HYDROXYPROGESTERONE ,PROGESTERONE ,AMNIOTIC liquid ,CERVIX uteri ,PREMATURE infants ,LONGITUDINAL method ,MATERNAL age ,RESEARCH funding ,THERAPEUTICS - Abstract
Objective: To evaluate whether the presence of cervical funneling or intra-amniotic debris identified in the second trimester is associated with a higher rate of preterm birth (PTB) in asymptomatic nulliparous pregnant women with a midtrimester cervical length (CL) less than 30 mm (i.e. below the 10th percentile).Methods: This was a secondary cohort analysis of data from a multicenter trial in nulliparous women between 16 and 22 weeks' gestation with a singleton gestation and CL less than 30 mm on transvaginal ultrasound, randomized to treatment with either 17-alpha-hydroxyprogesterone caproate or placebo. Sonographers were centrally certified in CL measurement, as well as in identification of intra-amniotic debris and cervical funneling. Univariable and multivariable analysis was performed to assess the associations of cervical funneling and intra-amniotic debris with PTB.Results: Of the 657 women randomized, 112 (17%) had cervical funneling only, 33 (5%) had intra-amniotic debris only and 45 (7%) had both on second-trimester ultrasound. Women with either of these findings had a shorter median CL than those without (21.0 mm vs 26.4 mm; P < 0.001). PTB prior to 37 weeks was more likely in women with cervical funneling (37% vs 21%; odds ratio (OR), 2.2 (95% CI, 1.5-3.3)) or intra-amniotic debris (35% vs 23%; OR, 1.7 (95% CI, 1.1-2.9)). Results were similar for PTB before 34 and before 32 weeks' gestation. After multivariable adjustment that included CL, PTB < 34 and < 32 weeks continued to be associated with the presence of intra-amniotic debris (adjusted OR (aOR), 1.85 (95% CI, 1.00-3.44) and aOR, 2.78 (95% CI, 1.42-5.45), respectively), but not cervical funneling (aOR, 1.17 (95% CI, 0.63-2.17) and aOR, 1.45 (95% CI, 0.71-2.96), respectively).Conclusions: Among asymptomatic nulliparous women with midtrimester CL less than 30 mm, the presence of intra-amniotic debris, but not cervical funneling, is associated with an increased risk for PTB before 34 and 32 weeks' gestation, independently of CL. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
12. Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth: a case-control study.
- Author
-
Manuck, T. A., Watkins, W. S., Esplin, M. S., Biggio, J., Bukowski, R., Parry, S., Zhan, H., Huang, H., Andrews, W., Saade, G., Sadovsky, Y., Reddy, U. M., Ilekis, J., Yandell, M., Varner, M. W., Jorde, L. B., the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN‐PBR), and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR)
- Subjects
HYDROXYPROGESTERONE ,CAPROATES ,PHARMACOGENOMICS ,PREMATURE labor ,PREMATURE labor prevention ,PROTEIN analysis ,GENE ontology - Abstract
Objective: To compare maternal genotypes between women with and without significant prolongation of pregnancy in the setting of 17-alpha hydroxyprogesterone caproate (17-P) administration for the prevention of recurrent preterm birth (PTB).Design: Case-control.Setting: Three tertiary-care centres across the USA.Population: Women (n = 99) with ≥ 1 prior singleton spontaneous PTB, receiving 17-P.Methods: Women were classified as having successful prolongation of pregnancy during the 17-P treated pregnancy, in two ways: (1) Definition A: success/non-success based on difference in gestational age at delivery between 17-P-treated and untreated pregnancies (success: delivered ≥ 3 weeks later with 17-P) and (2) Definition B: success/non-success based on reaching term (success: delivered at term with 17-P).Main Outcome Measures: To assess genetic variation, all women underwent whole exome sequencing. Between-group sequence variation was analysed with the Variant Annotation, Analysis, and Search Tool (VAAST). Genes scored by VAAST with P < 0.05 were then analysed with two online tools: (1) Protein ANalysis THrough Evolutionary Relationships (PANTHER) and (2) Database for Annotation, Visualization, and Integrated Discovery (DAVID).Results: Using Definition A, there were 70 women with successful prolongation and 29 without; 1375 genes scored by VAAST had P < 0.05. Using Definition B, 47 women had successful prolongation and 52 did not; 1039 genes scored by VAAST had P < 0.05. PANTHER revealed key differences in gene ontology pathways. Many genes from definition A were classified as prematurity genes (P = 0.026), and those from definition B as pharmacogenetic genes (P = 0.0018); (P, non-significant after Bonferroni correction).Conclusion: A novel analytic approach revealed several genetic differences among women delivering early vs later with 17-P.Tweetable Abstract: Several key genetic differences are present in women with recurrent preterm birth despite 17-P treatment. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
13. Neonatal complications associated with use of fetal scalp electrode: a retrospective study.
- Author
-
Kawakita, T, Reddy, UM, Landy, HJ, Iqbal, SN, Huang, C‐C, Grantz, KL, Reddy, U M, Landy, H J, Iqbal, S N, Huang, C-C, and Grantz, K L
- Subjects
PREGNANCY complication risk factors ,DELIVERY (Obstetrics) ,FETAL diseases ,GESTATIONAL age ,SCALP ,DISEASE risk factors ,WOUNDS & injuries ,FETAL heart rate monitoring equipment ,BIRTH injuries ,ELECTRODES ,FETAL heart rate monitoring ,RESEARCH funding ,DISEASE incidence ,RETROSPECTIVE studies ,ODDS ratio - Abstract
Objectives: To estimate the incidence and risk of complications associated with a fetal scalp electrode and to determine whether its application in the setting of operative vaginal delivery was associated with increased neonatal morbidity.Design: Retrospective cohort study.Setting: Twelve clinical centers with 19 hospitals across nine American Congress of Obstetricians and Gynecologists US districts.Population: Women in the USA.Methods: We evaluated 171 698 women with singleton deliveries ≥ 23 weeks of gestation in a secondary analysis of the Consortium on Safe Labor study between 2002 and 2008, after excluding conditions that precluded fetal scalp electrode application such as prelabour caesarean delivery. Secondary analysis limited to operative vaginal deliveries ≥ 34 weeks of gestation was also performed.Main Outcome Measures: Incidences and adjusted odds ratios with 95% confidence intervals of neonatal complications were calculated, controlling for maternal characteristics, delivery mode and pregnancy complications.Results: Fetal scalp electrode was used in 37 492 (22%) of deliveries. In non-operative vaginal delivery, fetal scalp electrode was associated with increased risk of injury to scalp due to birth trauma (1.2% versus 0.9%; adjusted odds ratios 1.62; 95% confidence intervals 1.41-1.86) and cephalohaematoma (1.0% versus 0.9%; adjusted odds ratios 1.57; 95% confidence intervals 1.36-1.83). Neonatal complications were not significantly different comparing fetal scalp electrode with vacuum-assisted vaginal delivery and vacuum-assisted vaginal delivery alone or comparing fetal scalp electrode with forceps-assisted vaginal delivery and forceps-assisted vaginal delivery alone.Conclusions: We found increased neonatal morbidity with fetal scalp electrode though the absolute risk was very low. It is possible that these findings reflect an underlying indication for its use. Our findings support the use of fetal scalp electrodes when clinically indicated.Tweetable Abstract: Neonatal risks associated with fetal scalp electrode use were low (injury to scalp 1.2% and cephalohaematoma 1.0%). [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
14. A Comparison of Obstetric Maneuvers for the Acute Management of Shoulder Dystocia
- Author
-
Hoffman, M. K., primary, Bailit, J. L., additional, Branch, D. W., additional, Burkman, R. T., additional, Van Veldhusien, P., additional, Lu, L., additional, Kominiarek, M. A., additional, Hibbard, J. U., additional, Landy, H. J., additional, Haberman, S., additional, Wilkins, I., additional, Quintero, V. H., additional, Gregory, K. D., additional, Hatjis, C. G., additional, Ramirez, M. M., additional, Reddy, U. M., additional, Troendle, J., additional, and Zhang, J., additional
- Published
- 2012
- Full Text
- View/download PDF
15. Using a simplified Bishop score to predict vaginal delivery (1).
- Author
-
Laughon, S. K., Zhang, J., Troendle, J., Sun, L., and Reddy, U. M.
- Abstract
Copyright of Revista Chilena de Obstetricia y Ginecología is the property of Revista Chilena de Obstetricia y Ginecologia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2011
16. Predictors of Sleep-disordered Breathing in Pregnancy.
- Author
-
Louis, J. M., Koch, M. A., Reddy, U. M., Silver, R. M., Parker, C. B., Facco, F. L., Redline, S., Nhan-Chang, C. L., Chung, J. H., Pien, G. W., Basner, R. C., Grobman, W. A., Wing, D. A., Simhan, H. N., Haas, D. M., Mercer, B. M., Parry, S., Mobley, D., Carper, B., and Saade, G. R.
- Published
- 2019
- Full Text
- View/download PDF
17. Nonmedically Indicated Induction in Morbidly Obese Women is Not Associated With an Increased Risk of Cesarean Delivery.
- Author
-
Kawakita, T., Iqbal, S. N., Huang, C. C., and Reddy, U. M.
- Published
- 2018
- Full Text
- View/download PDF
18. Maternal and Neonatal Outcomes With Early Compared With Delayed Pushing Among Nulliparous Women.
- Author
-
Yee, L. M., Sandoval, G., Bailit, J., Reddy, U. M., Wapner, R. J., Varner, M. W., Caritis, S. N., Prasad, M., Tita, A. T., Saade, G., Sorokin, Y., Rouse, D. J., Blackwell, S. C., and Tolosa, J. E.
- Published
- 2017
- Full Text
- View/download PDF
19. Neonatal Outcomes of Elective Early-term Births After Demonstrated Fetal Lung Maturity.
- Author
-
Tita, A. T. N., Jablonski, K. A., Bailit, J. L., Grobman, W. A., Wapner, R. J., Reddy, U. M., Varner, M. W., Thorp Jr., J. M., Leveno, K. J., Caritis, S. N., Iams, J. D., Saade, G., Sorokin, Y., Rouse, D. J., Blackwell, S. C., and Tolosa, J. E.
- Published
- 2019
- Full Text
- View/download PDF
20. Defining Failed Induction of Labor.
- Author
-
Grobman, W. A., Bailit, J., Lai, Y., Reddy, U. M., Wapner, R. J., Varner, M. W., Thorp Jr, J. M., Leveno, K. J., Caritis, S. N., Prasad, M., Tita, A. T. N., Saade, G., Sorokin, Y., Rouse, D. J., Blackwell, S. C., and Tolosa, J. E.
- Published
- 2018
- Full Text
- View/download PDF
21. Reassessing the Duration of the Second Stage of Labor in Relation to Maternal and Neonatal Morbidity.
- Author
-
Grantz, K. L., Sundaram, R., Ma, L., Hinkle, S., Berghella, V., Hoffman, M. K., and Reddy, U. M.
- Published
- 2018
- Full Text
- View/download PDF
22. Obstetric complications among US women with asthma.
- Author
-
Mendola, P., Laughon, S. K., M&3228;nnistö, T. I., Leishear, K., Reddy, U. M., Chen, Z., and Zhang, J.
- Published
- 2013
23. A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.
- Author
-
Hughes, B. L., Clifton, R. G., Rouse, D. J., Saade, G. R., Dinsmoor, M. J., Reddy, U. M., Pass, R., Allard, D., Mallett, G., Fette, L. M., Gyamfi-Bannerman, C., Varner, M. W., Goodnight, W. H., Tita, A. T. N., Costantine, M. M., Swamy, G. K., Gibbs, R. S., Chien, E. K., Chauhan, S. P., and El-Sayed, Y. Y.
- Subjects
- *
CYTOMEGALOVIRUS diseases , *GLOBULINS , *INFECTION , *NEONATAL infections , *PREGNANT women - Abstract
Background: Primary cytomegalovirus (CMV) infection during pregnancy carries a risk of congenital infection and possible severe sequelae. There is no established intervention for preventing congenital CMV infection.Methods: In this multicenter, double-blind trial, pregnant women with primary CMV infection diagnosed before 24 weeks' gestation were randomly assigned to receive a monthly infusion of CMV hyperimmune globulin (at a dose of 100 mg per kilogram of body weight) or matching placebo until delivery. The primary outcome was a composite of congenital CMV infection or fetal or neonatal death if CMV testing of the fetus or neonate was not performed.Results: From 2012 to 2018, a total of 206,082 pregnant women were screened for primary CMV infection before 23 weeks of gestation; of the 712 participants (0.35%) who tested positive, 399 (56%) underwent randomization. The trial was stopped early for futility. Data on the primary outcome were available for 394 participants; a primary outcome event occurred in the fetus or neonate of 46 of 203 women (22.7%) in the group that received hyperimmune globulin and of 37 of 191 women (19.4%) in the placebo group (relative risk, 1.17; 95% confidence interval [CI] 0.80 to 1.72; P = 0.42). Death occurred in 4.9% of fetuses or neonates in the hyperimmune globulin group and in 2.6% in the placebo group (relative risk, 1.88; 95% CI, 0.66 to 5.41), preterm birth occurred in 12.2% and 8.3%, respectively (relative risk, 1.47; 95% CI, 0.81 to 2.67), and birth weight below the 5th percentile occurred in 10.3% and 5.4% (relative risk, 1.92; 95% CI, 0.92 to 3.99). One participant in the hyperimmune globulin group had a severe allergic reaction to the first infusion. Participants who received hyperimmune globulin had a higher incidence of headaches and shaking chills while receiving infusions than participants who received placebo.Conclusions: Among pregnant women, administration of CMV hyperimmune globulin starting before 24 weeks' gestation did not result in a lower incidence of a composite of congenital CMV infection or perinatal death than placebo. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Center for Advancing Translational Sciences; ClinicalTrials.gov number, NCT01376778.). [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
24. Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy.
- Author
-
Casey, B. M., Thom, E. A., Peaceman, A. M., Varner, M. W., Sorokin, Y., Hirtz, D. G., Reddy, U. M., Wapner, R. J., Thorp Jr., J. M., Saade, G., Tita, A. T. N., Rouse, D. J., Sibai, B., Lams, J. D., Mercer, B. M., Tolosa, J., Caritis, S. N., VanDorsten, J. P., Casey, Brian M, and Thom, Elizabeth A
- Subjects
- *
HYPOTHYROIDISM treatment , *THYROXINE , *LEVOTHYROXINE , *PREGNANCY complications , *COGNITIVE ability , *THERAPEUTICS , *DEVELOPMENTAL disabilities , *COMPARATIVE studies , *HYPOTHYROIDISM , *INTELLECT , *INTELLIGENCE tests , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *PEOPLE with intellectual disabilities , *RESEARCH , *EVALUATION research , *RANDOMIZED controlled trials , *TREATMENT effectiveness , *PREVENTION ,DIAGNOSIS of developmental disabilities - Abstract
Background: Subclinical thyroid disease during pregnancy may be associated with adverse outcomes, including a lower-than-normal IQ in offspring. It is unknown whether levothyroxine treatment of women who are identified as having subclinical hypothyroidism or hypothyroxinemia during pregnancy improves cognitive function in their children.Methods: We screened women with a singleton pregnancy before 20 weeks of gestation for subclinical hypothyroidism, defined as a thyrotropin level of 4.00 mU or more per liter and a normal free thyroxine (T4) level (0.86 to 1.90 ng per deciliter [11 to 24 pmol per liter]), and for hypothyroxinemia, defined as a normal thyrotropin level (0.08 to 3.99 mU per liter) and a low free T4 level (<0.86 ng per deciliter). In separate trials for the two conditions, women were randomly assigned to receive levothyroxine or placebo. Thyroid function was assessed monthly, and the levothyroxine dose was adjusted to attain a normal thyrotropin or free T4 level (depending on the trial), with sham adjustments for placebo. Children underwent annual developmental and behavioral testing for 5 years. The primary outcome was the IQ score at 5 years of age (or at 3 years of age if the 5-year examination was missing) or death at an age of less than 3 years.Results: A total of 677 women with subclinical hypothyroidism underwent randomization at a mean of 16.7 weeks of gestation, and 526 with hypothyroxinemia at a mean of 17.8 weeks of gestation. In the subclinical hypothyroidism trial, the median IQ score of the children was 97 (95% confidence interval [CI], 94 to 99) in the levothyroxine group and 94 (95% CI, 92 to 96) in the placebo group (P=0.71). In the hypothyroxinemia trial, the median IQ score was 94 (95% CI, 91 to 95) in the levothyroxine group and 91 (95% CI, 89 to 93) in the placebo group (P=0.30). In each trial, IQ scores were missing for 4% of the children. There were no significant between-group differences in either trial in any other neurocognitive or pregnancy outcomes or in the incidence of adverse events, which was low in both groups.Conclusions: Treatment for subclinical hypothyroidism or hypothyroxinemia beginning between 8 and 20 weeks of gestation did not result in significantly better cognitive outcomes in children through 5 years of age than no treatment for those conditions. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke; ClinicalTrials.gov number, NCT00388297 .). [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
25. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery.
- Author
-
Gyamfi-Bannerman, C., Thom, E. A., Blackwell, S. C., Tita, A. T. N., Reddy, U. M., Saade, G. R., Rouse, D. J., McKenna, D. S., Clark, E. A. S., Thorp, Jr., J. M., Chien, E. K., Peaceman, A. M., Gibbs, R. S., Swamy, G. K., Norton, M. E., Casey, B. M., Caritis, S. N., Tolosa, J. E., Sorokin, Y., and VanDorsten, J. P.
- Subjects
- *
BRONCHOPULMONARY dysplasia prevention , *RESPIRATORY disease prevention , *PREMATURE infant disease prevention , *PULMONARY surfactant , *ARTIFICIAL respiration , *BRONCHOPULMONARY dysplasia , *COMPARATIVE studies , *GESTATIONAL age , *GLUCOCORTICOIDS , *HYPOGLYCEMIA , *PREMATURE infants , *PREMATURE infant diseases , *INTRAMUSCULAR injections , *PREMATURE labor , *RESEARCH methodology , *MEDICAL cooperation , *OXYGEN therapy , *PREGNANCY complications , *THIRD trimester of pregnancy , *RESEARCH , *STEROIDS , *EVALUATION research , *RANDOMIZED controlled trials , *THERAPEUTICS - Abstract
Background: Infants who are born at 34 to 36 weeks of gestation (late preterm) are at greater risk for adverse respiratory and other outcomes than those born at 37 weeks of gestation or later. It is not known whether betamethasone administered to women at risk for late preterm delivery decreases the risks of neonatal morbidities.Methods: We conducted a multicenter, randomized trial involving women with a singleton pregnancy at 34 weeks 0 days to 36 weeks 5 days of gestation who were at high risk for delivery during the late preterm period (up to 36 weeks 6 days). The participants were assigned to receive two injections of betamethasone or matching placebo 24 hours apart. The primary outcome was a neonatal composite of treatment in the first 72 hours (the use of continuous positive airway pressure or high-flow nasal cannula for at least 2 hours, supplemental oxygen with a fraction of inspired oxygen of at least 0.30 for at least 4 hours, extracorporeal membrane oxygenation, or mechanical ventilation) or stillbirth or neonatal death within 72 hours after delivery.Results: The primary outcome occurred in 165 of 1427 infants (11.6%) in the betamethasone group and 202 of 1400 (14.4%) in the placebo group (relative risk in the betamethasone group, 0.80; 95% confidence interval [CI], 0.66 to 0.97; P=0.02). Severe respiratory complications, transient tachypnea of the newborn, surfactant use, and bronchopulmonary dysplasia also occurred significantly less frequently in the betamethasone group. There were no significant between-group differences in the incidence of chorioamnionitis or neonatal sepsis. Neonatal hypoglycemia was more common in the betamethasone group than in the placebo group (24.0% vs. 15.0%; relative risk, 1.60; 95% CI, 1.37 to 1.87; P<0.001).Conclusions: Administration of betamethasone to women at risk for late preterm delivery significantly reduced the rate of neonatal respiratory complications. (Funded by the National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; ClinicalTrials.gov number, NCT01222247.). [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
26. Maternal serum fructosamine levels and stillbirth: a case-control study of the Stillbirth Collaborative Research Network.
- Author
-
Arslan E, Allshouse AA, Page JM, Varner MW, Thorsten V, Parker C, Dudley DJ, Saade GR, Goldenberg RL, Stoll BJ, Hogue CJ, Bukowski R, Conway D, Pinar H, Reddy UM, and Silver RM
- Subjects
- Adult, Case-Control Studies, Causality, Female, Humans, Live Birth epidemiology, Pregnancy, ROC Curve, Risk Factors, United States epidemiology, Fructosamine blood, Stillbirth epidemiology
- Abstract
Objective: To evaluate the association between maternal fructosamine levels at the time of delivery and stillbirth., Design: Secondary analysis of a case-control study., Setting: Multicentre study of five geographic catchment areas in the USA., Population: All singleton stillbirths with known diabetes status and fructosamine measurement, and representative live birth controls., Main Outcome Measures: Fructosamine levels in stillbirths and live births among groups were adjusted for potential confounding factors, including diabetes. Optimal thresholds of fructosamine to discriminate stillbirth and live birth., Results: A total of 529 women with a stillbirth and 1499 women with a live birth were included in the analysis. Mean fructosamine levels were significantly higher in women with a stillbirth than in women with a live birth after adjustment (177 ± 3.05 versus 165 ± 2.89 μmol/L, P < 0.001). The difference in fructosamine levels between stillbirths and live births was greater among women with diabetes (194 ± 8.54 versus 162 ± 3.21 μmol/L), compared with women without diabetes (171 ± 2.50 versus 162 ± 2.56 μmol/L). The area under the curve (AUC) for fructosamine level and stillbirth was 0.634 (0.605-0.663) overall, 0.713 (0.624-0.802) with diabetes and 0.625 (0.595-0.656) with no diabetes., Conclusions: Maternal fructosamine levels at the time of delivery were higher in women with stillbirth compared with women with live birth. Differences were substantial in women with diabetes, suggesting a potential benefit of glycaemic control in women with diabetes during pregnancy. The small differences noted in women without diabetes are not likely to justify routine screening in all cases of stillbirth., Tweetable Abstract: Maternal serum fructosamine levels are higher in women with stillbirth than in women with live birth, especially in women with diabetes., (© 2021 John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
27. Chronic hypertension, perinatal mortality and the impact of preterm delivery: a population-based study.
- Author
-
Grover S, Brandt JS, Reddy UM, and Ananth CV
- Subjects
- Adolescent, Adult, Causality, Cross-Sectional Studies, Female, Gestational Age, Humans, Infant, Newborn, Pregnancy, Retrospective Studies, Risk Factors, United States epidemiology, Young Adult, Delivery, Obstetric statistics & numerical data, Hypertension epidemiology, Perinatal Death, Pregnancy Complications, Cardiovascular epidemiology, Premature Birth epidemiology
- Abstract
Objectives: To estimate the association between chronic hypertension and perinatal mortality and to evaluate the extent to which risks are impacted by preterm delivery., Design: Cross-sectional analysis., Setting: United States, 2015-18., Population: Singleton births (20-44 weeks of gestation)., Exposure: Chronic hypertension, defined as elevated blood pressure diagnosed before pregnancy or recognised before 20 weeks of gestation., Main Outcomes and Measures: We derived the risk of perinatal mortality in relation to chronic hypertension from Poisson models, adjusted for confounders. The impacts of misclassification and unmeasured confounding were assessed. Causal mediation analysis was performed to quantify the impact of preterm delivery on the association., Results: Of the 15 090 678 singleton births, perinatal mortality rates were 22.5 and 8.2 per 1000 births in chronic hypertensive and normotensive pregnancies, respectively (adjusted risk ratio 2.05, 95% CI 2.00-2.10). Corrections for exposure misclassification and unmeasured confounding biases substantially increased the risk estimate. Although causal mediation analysis revealed that most of the association of chronic hypertension on perinatal mortality was mediated through preterm delivery, the perinatal mortality rates were highest at early term, term and late term gestations, suggesting that a planned early term delivery at 37-38
6/7 weeks may optimally balance risk in these pregnancies. Additionally, 87% (95% CI 84-90%) of perinatal deaths could be eliminated if preterm deliveries, as a result of chronic hypertension, were preventable., Conclusions: Chronic hypertension is associated with increased risk for perinatal mortality. Planned early term delivery and targeting modifiable risk factors for chronic hypertension may reduce perinatal mortality rates., Tweetable Abstract: Maternal chronic hypertension is associated with increased risk for perinatal mortality, largely driven by preterm birth., (© 2021 John Wiley & Sons Ltd.)- Published
- 2022
- Full Text
- View/download PDF
28. Severe maternal morbidity during delivery hospitalisation in a large international administrative database, 2008-2013: a retrospective cohort.
- Author
-
Lipkind HS, Zuckerwise LC, Turner EB, Collins JJ, Campbell KH, Reddy UM, Illuzi JL, and Merriam AA
- Subjects
- Adult, Australia epidemiology, Centers for Disease Control and Prevention, U.S., Comorbidity, Databases, Factual, England epidemiology, Female, Humans, Maternal Age, Middle Aged, Obstetric Labor Complications physiopathology, Pregnancy, Pregnancy Complications physiopathology, Pregnancy Outcome, Retrospective Studies, Risk Factors, United States epidemiology, Young Adult, Hospitalization statistics & numerical data, Maternal Death statistics & numerical data, Obstetric Labor Complications epidemiology, Pregnancy Complications epidemiology
- Abstract
Objective: This study utilized the Dr. Foster Global Comparators database to identify pregnancy complications and associated risk factors that led to severe maternal morbidity during delivery hospitalisations in large university hospitals based in the USA, Australia, and England., Design: Retrospective cohort., Setting: Births in the USA, England and Australia from 2008 to 2013., Sample: Data from delivery hospitalisations between 2008 and 2013 were examined using the Dr. Foster Global Comparators database., Methods: We identified delivery hospitalisations with life-threatening diagnoses or use of life-saving procedures, using algorithms for severe maternal morbidity from the Center for Disease Control. Frequency of severe maternal morbidity was calculated for each country., Main Outcome Measures: Multivariable analysis was used to examine the association between morbidity and socio-demographic and clinical characteristics within each country. Chi-square tests assessed differences in covariates between countries., Results: From 2008 to 2013, there were 516 781 deliveries from a total of 18 hospitals: 24.5% from the USA, 57.0% from England and 18.4% from Australia. Overall severe maternal morbidity rate was 8.2 per 1000 deliveries: 15.6 in the USA, 5.0 in England, and 8.2 in Australia. The most common codes identifying severe morbidity included transfusion, disseminated intravascular coagulation, acute renal failure, cardiac events/procedures, ventilation, hysterectomy, and eclampsia. Advanced maternal age, hypertension, diabetes, and substance abuse were associated with severe maternal morbidity in all three countries., Conclusion: Rates of severe maternal morbidity differed by country. Identification of geographical, socio-demographic, and clinical differences can help target modifications of practice and potentially reduce severe maternal morbidity., Tweetable Abstract: Rates of severe maternal morbidity vary, but risk factors associated with adverse outcomes are similar in developed countries., (© 2019 Royal College of Obstetricians and Gynaecologists.)
- Published
- 2019
- Full Text
- View/download PDF
29. Predicting Vaginal Delivery in Nulliparous Women Undergoing Induction of Labor at Term.
- Author
-
Kawakita T, Reddy UM, Huang CC, Auguste TC, Bauer D, and Overcash RT
- Subjects
- Adult, Female, Humans, Labor, Induced adverse effects, Logistic Models, Nomograms, Pregnancy, ROC Curve, Retrospective Studies, Risk Factors, Term Birth, Treatment Failure, United States, Young Adult, Cesarean Section statistics & numerical data, Labor, Induced statistics & numerical data, Parity
- Abstract
Objective: We sought to develop a model to calculate the likelihood of vaginal delivery in nulliparous women undergoing induction at term., Study Design: We obtained data from the Consortium on Safe Labor by including nulliparous women with term singleton pregnancies undergoing induction of labor at term. Women with contraindications for vaginal delivery were excluded. A stepwise logistic regression analysis was used to identify the predictors associated with vaginal delivery by considering maternal characteristics and comorbidities and fetal conditions. The receiver operating characteristic curve, with an area under the curve (AUC) was used to assess the accuracy of the model., Results: Of 10,591 nulliparous women who underwent induction of labor, 8,202 (77.4%) women had vaginal delivery. Our model identified maternal age, gestational age at delivery, race, maternal height, prepregnancy weight, gestational weight gain, cervical exam on admission (dilation, effacement, and station), chronic hypertension, gestational diabetes, pregestational diabetes, and abruption as significant predictors for successful vaginal delivery. The overall predictive ability of the final model, as measured by the AUC was 0.759 (95% confidence interval, 0.749-0.770)., Conclusion: We identified independent risk factors that can be used to predict vaginal delivery among nulliparas undergoing induction at term. Our predictor provides women with additional information when considering induction., Competing Interests: None., (Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.)
- Published
- 2018
- Full Text
- View/download PDF
30. Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth: a case-control study.
- Author
-
Manuck TA, Watkins WS, Esplin MS, Biggio J, Bukowski R, Parry S, Zhan H, Huang H, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J, Yandell M, Varner MW, and Jorde LB
- Subjects
- Adult, Analysis of Variance, Case-Control Studies, Female, Gestational Age, Humans, Pharmacogenetics, Pregnancy, Pregnancy Outcome epidemiology, Progestins therapeutic use, Recurrence, United States epidemiology, Exome Sequencing methods, Exome Sequencing statistics & numerical data, 17 alpha-Hydroxyprogesterone Caproate therapeutic use, Premature Birth epidemiology, Premature Birth genetics, Premature Birth prevention & control
- Abstract
Objective: To compare maternal genotypes between women with and without significant prolongation of pregnancy in the setting of 17-alpha hydroxyprogesterone caproate (17-P) administration for the prevention of recurrent preterm birth (PTB)., Design: Case-control., Setting: Three tertiary-care centres across the USA., Population: Women (n = 99) with ≥ 1 prior singleton spontaneous PTB, receiving 17-P., Methods: Women were classified as having successful prolongation of pregnancy during the 17-P treated pregnancy, in two ways: (1) Definition A: success/non-success based on difference in gestational age at delivery between 17-P-treated and untreated pregnancies (success: delivered ≥ 3 weeks later with 17-P) and (2) Definition B: success/non-success based on reaching term (success: delivered at term with 17-P)., Main Outcome Measures: To assess genetic variation, all women underwent whole exome sequencing. Between-group sequence variation was analysed with the Variant Annotation, Analysis, and Search Tool (VAAST). Genes scored by VAAST with P < 0.05 were then analysed with two online tools: (1) Protein ANalysis THrough Evolutionary Relationships (PANTHER) and (2) Database for Annotation, Visualization, and Integrated Discovery (DAVID)., Results: Using Definition A, there were 70 women with successful prolongation and 29 without; 1375 genes scored by VAAST had P < 0.05. Using Definition B, 47 women had successful prolongation and 52 did not; 1039 genes scored by VAAST had P < 0.05. PANTHER revealed key differences in gene ontology pathways. Many genes from definition A were classified as prematurity genes (P = 0.026), and those from definition B as pharmacogenetic genes (P = 0.0018); (P, non-significant after Bonferroni correction)., Conclusion: A novel analytic approach revealed several genetic differences among women delivering early vs later with 17-P., Tweetable Abstract: Several key genetic differences are present in women with recurrent preterm birth despite 17-P treatment., (© 2017 Royal College of Obstetricians and Gynaecologists.)
- Published
- 2018
- Full Text
- View/download PDF
31. Neonatal complications associated with use of fetal scalp electrode: a retrospective study.
- Author
-
Kawakita T, Reddy UM, Landy HJ, Iqbal SN, Huang CC, and Grantz KL
- Subjects
- Adult, Birth Injuries epidemiology, Cardiotocography adverse effects, Delivery, Obstetric methods, Female, Humans, Incidence, Infant, Newborn, Odds Ratio, Pregnancy, Retrospective Studies, Scalp embryology, United States epidemiology, Birth Injuries etiology, Cardiotocography instrumentation, Delivery, Obstetric adverse effects, Electrodes adverse effects, Scalp injuries
- Abstract
Objectives: To estimate the incidence and risk of complications associated with a fetal scalp electrode and to determine whether its application in the setting of operative vaginal delivery was associated with increased neonatal morbidity., Design: Retrospective cohort study., Setting: Twelve clinical centers with 19 hospitals across nine American Congress of Obstetricians and Gynecologists US districts., Population: Women in the USA., Methods: We evaluated 171 698 women with singleton deliveries ≥ 23 weeks of gestation in a secondary analysis of the Consortium on Safe Labor study between 2002 and 2008, after excluding conditions that precluded fetal scalp electrode application such as prelabour caesarean delivery. Secondary analysis limited to operative vaginal deliveries ≥ 34 weeks of gestation was also performed., Main Outcome Measures: Incidences and adjusted odds ratios with 95% confidence intervals of neonatal complications were calculated, controlling for maternal characteristics, delivery mode and pregnancy complications., Results: Fetal scalp electrode was used in 37 492 (22%) of deliveries. In non-operative vaginal delivery, fetal scalp electrode was associated with increased risk of injury to scalp due to birth trauma (1.2% versus 0.9%; adjusted odds ratios 1.62; 95% confidence intervals 1.41-1.86) and cephalohaematoma (1.0% versus 0.9%; adjusted odds ratios 1.57; 95% confidence intervals 1.36-1.83). Neonatal complications were not significantly different comparing fetal scalp electrode with vacuum-assisted vaginal delivery and vacuum-assisted vaginal delivery alone or comparing fetal scalp electrode with forceps-assisted vaginal delivery and forceps-assisted vaginal delivery alone., Conclusions: We found increased neonatal morbidity with fetal scalp electrode though the absolute risk was very low. It is possible that these findings reflect an underlying indication for its use. Our findings support the use of fetal scalp electrodes when clinically indicated., Tweetable Abstract: Neonatal risks associated with fetal scalp electrode use were low (injury to scalp 1.2% and cephalohaematoma 1.0%)., Competing Interests: of interest: The authors report no conflicts of interest. The ICMJE disclosure forms are available as online supporting information., (© 2015 Royal College of Obstetricians and Gynaecologists.)
- Published
- 2016
- Full Text
- View/download PDF
32. Unravelling caesarean delivery as a risk factor for antepartum stillbirth.
- Author
-
Reddy UM
- Subjects
- Female, Humans, Pregnancy, Cesarean Section adverse effects, Stillbirth epidemiology
- Published
- 2015
- Full Text
- View/download PDF
33. The association of beta-2 adrenoceptor genotype with short-cervix mediated preterm birth: a case-control study.
- Author
-
Miller R, Smiley R, Thom EA, Grobman WA, Iams JD, Mercer BM, Saade G, Tita AT, Reddy UM, Rouse DJ, Sorokin Y, Blackwell SC, Esplin MS, Tolosa JE, and Caritis SN
- Subjects
- Adult, Case-Control Studies, Cervical Length Measurement, Female, Genetic Markers, Homozygote, Humans, Polymorphism, Single Nucleotide, Pregnancy, Pregnancy Trimester, Second, Prospective Studies, Uterine Cervical Incompetence diagnostic imaging, Genotype, Premature Birth etiology, Receptors, Adrenergic, beta-2 genetics, Uterine Cervical Incompetence genetics
- Abstract
Objective: To determine whether β2 -adrenoceptor (β2 AR) genotype is associated with shortening of the cervix or with preterm birth (PTB) risk among women with a short cervix in the second trimester., Design: A case-control ancillary study to a multicentre randomised controlled trial., Setting: Fourteen participating centres of the Maternal-Fetal Medicine Units Network of the Eunice Kennedy Shriver National Institute of Child Health and Human Development., Population: Four hundred thirty-nine women, including 315 with short cervix and 124 with normal cervical length., Methods: Nulliparous women with cervical length <30 mm upon a 16-22-week transvaginal sonogram and controls frequency-matched for race/ethnicity with cervical lengths ≥40 mm were studied. β2 AR genotype was determined at positions encoding for amino acid residues 16 and 27., Main Outcome Measures: Genotype distributions were compared between case and control groups. Within the short cervix group, pregnancy outcomes were compared by genotype, with a primary outcome of PTB <37 weeks., Results: Genotype data were available at position 16 for 433 women and at position 27 for 437. Using a recessive model testing for association between short cervix and genotype, and adjusted for ethnicity, there was no statistical difference between cases and controls for Arg16 homozygosity (OR 0.7, 95% CI 0.4-1.3) or Gln27 homozygosity (OR 0.9, 95% CI 0.3-2.7). Among cases, Arg16 homozygosity was not associated with protection from PTB or spontaneous PTB. Gln27 homozygosity was not associated with PTB risk, although sample size was limited., Conclusions: β2 AR genotype does not seem to be associated with short cervical length or with PTB following the second-trimester identification of a short cervix. Influences on PTB associated with β2 AR genotype do not appear to involve a short cervix pathway., (© 2015 Royal College of Obstetricians and Gynaecologists.)
- Published
- 2015
- Full Text
- View/download PDF
34. In vitro sealing of punctured fetal membranes: potential treatment for midtrimester premature rupture of membranes.
- Author
-
Reddy UM, Shah SS, Nemiroff RL, Ballas SK, Hyslop T, Chen J, Wapner RJ, and Sciscione AC
- Subjects
- Amnion metabolism, Amniotic Fluid metabolism, Blood Platelets physiology, Female, Humans, In Vitro Techniques, Injections, Permeability, Pregnancy, Pregnancy Trimester, Second, Punctures, Time Factors, Amnion drug effects, Fetal Membranes, Premature Rupture drug therapy, Fibrin Tissue Adhesive therapeutic use, Thrombin therapeutic use, Tissue Adhesives therapeutic use
- Abstract
Objective: Midtrimester premature rupture of membranes causes significant perinatal morbidity and death. No effective treatment exists. We investigated (1) whether a needle puncture in the fetal membranes could be sealed in vitro and (2) the optimal composition of the sealant to be used., Study Design: Membranes from second trimester pregnancies (16-24 weeks of gestation) were stretched over a modified syringe with a 2.5-cm open diameter. The syringe was filled with 20 mL of second trimester amniotic fluid, and the membrane was punctured with a 20-gauge needle. Sealants were injected into the amniotic fluid. The primary outcome variable was time for leakage of amniotic fluid. Median times for leakage for the formulations were compared by Wilcoxon exact rank sum test., Results: Platelets alone failed to seal the puncture site. All other formulations stopped leakage temporarily. Tisseel (Baxter Corp, Glendale, Calif) and cryoprecipitate/thrombin preparations led to more prolonged sealing of punctured amniotic membranes than platelets (P <.01) and were not significantly different from each other., Conclusion: Of the sealants tested in vitro, amniotic membranes are best sealed by a fibrin/thrombin-based sealant.
- Published
- 2001
- Full Text
- View/download PDF
35. Population adjustment of the definition of the vaginal birth after cesarean rate.
- Author
-
Reddy UM, DiVito MM, Armstrong JC, Hyslop T, and Wapner RJ
- Subjects
- Female, Health Personnel classification, Health Personnel statistics & numerical data, Humans, Patient Selection, Pregnancy, Risk Factors, Vaginal Birth after Cesarean statistics & numerical data
- Abstract
Objective: The vaginal birth after cesarean delivery rate is calculated with a denominator equal to the number of all women who give birth after a previous cesarean delivery, including those who are not candidates for a trial of labor. We evaluated the impact of adjustment for noncandidates for a trial of labor on vaginal birth after cesarean delivery rates., Study Design: All women with a previous cesarean delivery who were delivered during 1998 were classified as either candidates or noncandidates for a trial of labor. An adjusted vaginal birth after cesarean delivery rate was calculated by eliminating noncandidates for a trial of labor from the denominator. The percentage of noncandidates for a trial of labor, the vaginal birth after cesarean delivery rate, and the adjusted vaginal birth after cesarean delivery rate were compared among 3 clinical services., Results: The maternal-fetal medicine service had a significantly higher percentage of noncandidates for a trial of labor than did either the low-risk resident clinic or the low-risk private service. The maternal-fetal medicine service had a significantly lower vaginal birth after cesarean delivery rate than did the private service, but this difference was no longer present after application of an adjusted vaginal birth after cesarean delivery definition., Conclusion: For accurate comparison of vaginal birth after cesarean delivery rates among providers it is essential to account for patient risk status in the vaginal birth after cesarean delivery definition through the elimination of noncandidates for a trial of labor.
- Published
- 2000
- Full Text
- View/download PDF
36. Differentiating lymphocytic adenohypophysitis from pituitary adenoma in the peripartum patient.
- Author
-
Pressman EK, Zeidman SM, Reddy UM, Epstein JI, and Brem H
- Subjects
- Diagnosis, Differential, Female, Humans, Inflammation diagnosis, Lymphocytes, Pituitary Gland, Anterior, Pregnancy, Retrospective Studies, Autoimmune Diseases diagnosis, Pituitary Diseases diagnosis, Pituitary Neoplasms diagnosis, Pregnancy Complications diagnosis, Pregnancy Complications, Neoplastic diagnosis, Prolactinoma diagnosis
- Abstract
Lymphocytic adenohypophysitis (LAH) is an autoimmune disorder of the pituitary gland with a predilection for the peripartum period and often mimics a pituitary adenoma. We sought to define the clinical, endocrinologic and radiographic characteristics differentiating peripartum LAH from pituitary adenoma to enable the use of noninvasive diagnosis and appropriate therapy. From published reports and our own case, the clinical histories and laboratory and radiographic studies of 45 patients fulfilling the diagnosis of peripartum LAH were reviewed. History of infertility or menstrual irregularity, symptomatology, endocrinologic evaluation, diagnostic imaging and associated medical conditions were analyzed. For comparison, 806 patients with pituitary adenoma and pregnancy from published series were evaluated. The spontaneous pregnancy rate in pituitary adenoma patients was 2.4% vs. 100% in LAH patients. Visual disturbances and headaches were significantly more frequent in patients with LAH. Prolactin levels were significantly lower in patients with LAH than in those with pituitary adenomas (34.6 +/- 46.3 [SD] vs. 393.0 +/- 300.4, P < .0001). Abnormalities in thyroid and/or adrenal function were also more common in patients with LAH (57.5% vs. 2.5%, P < .001). There were no distinguishing characteristics on radiographic studies. History and endocrinologic evaluation can differentiate between LAH and pituitary adenoma in the peripartum patient.
- Published
- 1995
37. Cholelithiasis of the ovary.
- Author
-
Tursi JP, Reddy UM, and Huggins G
- Subjects
- Aged, Cholelithiasis complications, Cholelithiasis surgery, Female, Humans, Calculi etiology, Cholecystectomy adverse effects, Ovarian Diseases etiology
- Abstract
Background: Laparoscopic cholecystectomy is becoming a popular surgical option in the management of gallstone disease. Reports on complications of this procedure have usually focused on prolonged operative time, bleeding, and infections. We describe a case of cholelithiasis of the ovary following laparoscopic cholecystectomy., Case: A 70-year-old woman, para 5-0-0-5, presented with a 2-month history of a pelvic mass following a laparoscopic cholecystectomy. Exploratory laparotomy demonstrated a 4 x 4-cm para-ovarian cyst as well as multiple rectal and pelvic implants. Pathologic findings confirmed gallstones of the ovary and pelvic peritoneum. These gallstones elicited mesothelial proliferation, local hemorrhage, and adhesion formation., Conclusion: The pathologic consequences of pelvic cholelithiasis can be marked. This was demonstrated in a postmenopausal woman, but has direct implications for the premenopausal patient as well. Our experience suggests that gallstones lost during laparoscopic cholecystectomy should be removed if possible.
- Published
- 1993
38. Fetal movement during labor.
- Author
-
Reddy UM, Paine LL, Gegor CL, Johnson MJ, and Johnson TR
- Subjects
- Female, Humans, Pregnancy, Time Factors, Transducers, Fetal Movement physiology, Heart Rate, Fetal physiology, Uterine Contraction
- Abstract
The prognostic significance of antepartum fetal movement is well known; therefore it may be a variable in intrapartum fetal well-being. We report the simultaneous observation of fetal movement with fetal heart rate and uterine contractions by processed Doppler actograph signals during spontaneous labor of 22 normal women with normal fetal outcome. The mean percent incidence of fetal movement during labor was 17.3%. The percentage occurring during uterine contractions was 65.9%. Of all uterine contractions, 89.8% were associated with fetal movement. The proportion of time the fetus spent moving during uterine contractions (21.4%) was higher than between uterine contractions (12.9%). Uterine contractions associated with fetal movement were significantly longer than those not associated with fetal movement (p less than 0.0001). Mean percent incidence of fetal movement did not differ significantly between latent and active-phase labor. This study demonstrates a clear relationship between fetal movement and uterine contractions in labor.
- Published
- 1991
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.